New 1-substituted 3,5-diaryl-2-pyrazolines 13-27 have been synthesized by the reaction of hydroxychalcones 1-12 and hydrazines in hot acetic acid solution. Structures of all new compounds have been elucidated by microanalyses, 1 H-and 13 C-NMR spectroscopy.
Introduction
Pyrazolines are prominent nitrogen-containing heterocyclic compounds and, therefore, various procedures have been worked out for their synthesis. [1] [2] [3] [4] Numerous pyrazoline type compounds have been found to possess useful bioactivity, e.g. antimicrobial, 5 central nervous system 6 and immunosuppressive. 7 Among the various pyrazoline isomers, 2-pyrazolines appear to be the most frequently investigated compounds. As a consequence, a large number of 2-pyrazolines have been described in the chemical literature, using different synthetic methods for their preparation. An especially popular procedure is based on the reaction of α,β-unsaturated aldehydes and ketones with hydrazines. However, series of specially substituted representatives have been prepared rarely. For this reason, the aim of our present study was to synthesize systematically hydroxylated 3,5-diaryl-2-pyrazolines for the study of their structureactivity relationships.
Results and Discussion
Formation of 2-pyrazolines by the reaction of α,β-unsaturated ketones and hydrazines may take place under various reaction conditions using ethanol, 18 acetic acid [8] [9] [10] 16, 21, [25] [26] [27] or pyridine 28, 29 as solvent. After some preliminary experiments, acetic acid was found to be a convenient solvent in our present case. Hydroxychalcones 1-12 were allowed to react with hydrazine hydrate or phenylhydrazine in hot acetic acid (cf. Experimental Section) to afford 1-substituted 3,5-diaryl-2-pyrazolines 13-27 in high yields (Scheme 1). N-Acetylation of all 2-pyrazolines obtained by the reaction of the appropriate chalcones with hydrazine has taken place under these reaction conditions in each case. Formation of the N-acetyl derivatives is beneficial since the 1-substituted 2-pyrazolines are stable compounds and can be used for biological and pharmaceutical trials without the risk of undesirable decomposition. 
Scheme 1
Structures of all new compounds 13-27 have been elucidated by elemental analyses, 1 H-and 13 C-NMR measurements. In the 1 H-NMR spectra of 2-pyrazolines 13-27, the three hydrogen atoms attached to the C-4 and C-5 carbon atoms of the heterocyclic ring gave an ABX spin system. Measured chemical shift and coupling constant values (cf. Experimental Section) unequivocally prove the 2-pyrazoline structure. In the 1 H-NMR spectra of 1-acetyl-2-pyrazolines 13-17, 21, 22 and 24-36 a singlet signal at around 2.4 ppm refers to the presence of an N-acetyl group. In the 13 C-NMR spectra of all new 1-substituted 3,5-diaryl-2-pyrazolines 13-27, the 1 H-NMR spectroscopic measurements. 13 C-NMR chemical shifts of the N-acetyl group also have been assigned in the case of compounds 13-17, 21, 22 and 24-26.
In conclusion, we have synthesized systematically hydroxylated 3,5-diaryl-2-pyrazolines by the reaction of hydrazines and chalcones bearing an ortho-, meta-or para-hydroxy group in their ring A. These new substances allow the investigation of the possible linkage of the 2-pyrazolines to various sites in living organisms in the course of the investigation of their bioactivities. The new 1-substituted 3,5-diaryl-2-pyrazolines described in this paper are very stable compounds, a property which may render them especially useful substances in drug research.
Experimental Section
General Procedures. Melting points were determined with a Koffler hot-stage apparatus and are uncorrected.
1 H-and 
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General procedure for the synthesis of compounds 13-27 A mixture of hydroxychalcone (1-12, 10.0 mmoles), hydrazine hydrate (50.0 mmoles) or phenylhydrazine (50.0 mmoles) and acetic acid (40 ml) was refluxed for 3 hours then poured into water. The precipitate was separated by filtration, washed free of acid and crystallized from methanol to afford 2-pyrazolines 13-27 (Scheme 1). 
1-Acetyl-3-(2-hydroxyphenyl)-5-(4-isopropylphenyl)-2-pyrazoline (13)
.
1-Acetyl-3-(3-hydroxyphenyl)-5-(4-methoxyphenyl)-2-pyrazoline (21

